NBK Capital Partners has acquired a majority stake in Polymedic, which is based in Morocco, the sixth largest pharmaceutical market in Africa that is expected to reach $2bn in 2020.
Dubai-based private equity firm NBK Capital Partners has announced the acquisition of Polymedic, a generics firm headquartered in Casablanca, Morocco.
NBK said that Morocco had become a “regional hub” for local and international pharma players, pointing out that it was...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
